During the past decade, Children's Center for Digestive Healthcare conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 16 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Center for Digestive Healthcare" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Shire" with 5 trials sponsored, "Celgene" with 4 trials sponsored, "Forest Laboratories" with 4 trials sponsored and "Takeda" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Center for Digestive Healthcare" #1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Ann & Robert H Lurie Children's Hospital of Chicago" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Arnold Palmer Hospital for Children" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Children's Center for Digestive Healthcare" are "Crohn Disease" (8 trials), "Ulcerative Colitis" (6 trials), "Eosinophilic Esophagitis" (5 trials), "Eosinophilic Esophagitis (EoE)" (5 trials) and "Colitis, Ulcerative" (4 trials). Many other conditions were trialed in "Children's Center for Digestive Healthcare" in a lesser frequency.

Most popular intervention types in "Children's Center for Digestive Healthcare" are "Drug" (32 trials), "Other" (5 trials), "Device" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ozanimod" (3 trials), "Ustekinumab" (3 trials), "Vedolizumab" (3 trials) and "EUR-1100" (2 trials). Other intervention names were less common.

The vast majority of trials in "Children's Center for Digestive Healthcare" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Children's Center for Digestive Healthcare". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Children's Center for Digestive Healthcare, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Center for Digestive Healthcare, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".